Navigation Links
IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery

MOUNTAIN VIEW, Calif., July 29 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.

The Adjustable Laser Probe speeds up treatments by allowing continuous adjustment of the optical fiber over a wide range of angles for full coverage of the peripheral retina without requiring removal and reinsertion of the probe from the eye.

"We continue to focus on ways to increase the value of our consumable instrumentation line by offering novel and creative product solutions to our ophthalmic customers which in turn will help us grow our business," stated Theodore A. Boutacoff, President and CEO, "and to reconfirm our corporate position as a leader in our market."

"The issuance of this patent is valuable to IRIDEX because it helps us maintain the differentiation of our vitreoretinal product line from those of our competitors, and we plan to capitalize on the leverage afforded by this new patent by expanding this product line in the near future."


IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the Company's ability to increase the value of its consumable products, grow its business, differentiate its products and increase its product offerings in the near future.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors. Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended January 2, 2010 which was filed with the Securities and Exchange Commission and in our Quarterly Report on Form 10-Q for the fiscal quarter ended April 3, 2010. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Announces First Commercial Shipment of New IQ 532(TM) Laser Systems
2. IRIDEX Announces First Quarter 2010 Conference Call and Release Date
3. IRIDEX Reports Fourth Quarter and Full Year 2009 Financial Results
4. IRIDEX Announces Fourth Quarter and Full Year 2009 Conference Call and Release Date
5. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
6. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
7. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
8. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
9. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
10. BSP Granted CE Mark for its HyperQ AD-100 Product Enabling Improved Diagnostic Performance of Stress ECG
11. Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitus
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
(Date:11/25/2015)... , Nov. 25, 2015 Endo International plc (NASDAQ: ... De Silva , President and CEO, will discuss corporate updates ... in New York on Wednesday, December ... . Click on Investor Relations, and then the link to ... the presentation,s start time to visit the site and download ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... The ... perfect dish and pleasing the palates of attendees is of the utmost importance. ... to a seasonal get-together, give these recipes a try this holiday season. , ...
(Date:11/25/2015)... Nairobi (PRWEB) , ... November 26, 2015 , ... ... African Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, ... Nations Office in Nairobi (UNON) for the opening of the 5th African Network ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like ... , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. ... OH. , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Smiles ... of TMJ Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of ... of the great success Botox® delivers to those suffering with discomfort, soreness, and pain ...
(Date:11/25/2015)... ... , ... “While riding the bus, I saw a passenger in a wheelchair ... to be a convenient and comfortable way to protect them from bad weather, so ... safely travel during cold or inclement weather. In doing so, it ensures that the ...
Breaking Medicine News(10 mins):